Costimulation of human natural killer cell proliferation: Role of accessory cytokines and cell contact-dependent signals

Natural Immunity

Volumn 15, Issue 5, 1997, Pages 213-226

  Robertson, Michael J ^a,b   Cameron, Christine ^a   Lazo, Susan ^a   Cochran, Keith J ^a   Voss, Stephan D ^a   Ritz, Jerome ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Costimulation; Interleukin 12; Interleukin 15; Interleukin 2; Natural killer cells; Profileration

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; IONOMYCIN; TUMOR NECROSIS FACTOR;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL CONTACT; CELL STRAIN K 562; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTIGENS, CD56; CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; IONOMYCIN; IONOPHORES; KILLER CELLS, NATURAL; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9844221953     PISSN: 10188916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 1990;76:2421-2438.
2. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989;47: 187-337.
3. Welsh RM: Regulation of virus infections by natural killer cells: A review. Nat Immun 1986;5:169-199.
4. Scharton TM, Scott P: Natural killer cells are a source of interferon γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993;178:567-577.
5. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor [interleukin-12 (IL-12)] induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
6. H2 responses: A key role for the 'natural' immune response? Immunol Today 1992;13:379-381.
7. Schmidt RE, Michon JM, Woronicz J, Schlossman SF, Reinherz EL, Ritz J: Enhancement of natural killer function through activation of the T11 E rosette receptor. J Clin Invest 1987;79:305-308.
8. Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL: Identification of an evolutionarily conserved, function-associated molecule on human natural killer cells. Proc Natl Acad Sci USA 1991;88: 3009-3013.
9. Valiante NM, Trinchieri G: Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993; 178:1397-1406.
10. Anderson SK, Gallinger S, Roder J, Frey J, Young HA, Ortaldo JR: A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci USA 1993;90: 542-546.
11. Lanier LL, Phillips JH: Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996; 17:86-91.
12. Gumperz JE, Parham P: The enigma of the natural killer cell. Nature 1995;378:245-248.
13. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B: Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 1984;160:1147-1169.
14. Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcR III-positive and negative natural killer cells. J Immunol 1989; 143:3183-3191.
15. Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J: Costimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol 1993;150:1705-1714.
16. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL: Response of human NK cells to IL-6: Alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-α/β secretion. J Immunol 1993;150:4844-4855.
17. Naume B, Gately M, Espevik T: A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 1992; 148:2429-2436.
18. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-1403.
19. Robertson MJ, Manley TJ, Pichert G, Cameron C, Cochran KJ, Levine H, Ritz J: Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma 1995;17:51-61.
20. Hercend T, Meuer S, Reinherz EL, Schlossman SF, Ritz J: Generation of a cloned NK cell line derived from the 'null cell' fraction of human peripheral blood. J Immunol 1982;129:1299-1305.
21. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J: Human natural killer cell adhesion molecules: Differential expression after activation and participation in cytolysis. J Immunol 1990;145:3194-3201.
22. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM: B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991;88:6575-6579.
23. Gollob JA, Li J, Kawasaki H, Daley JF, Groves C, Reinherz EL, Ritz J: Molecular interaction between CD58 and CD2 counterreceptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 1996;157:1886-1893.
24. Kobata T, Agematsu K, Kameoka J, Schlossman SF, Morimoto C: CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation. J Immunol 1994; 153:5422-5432.
25. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells is differentially regulated by NKSF. J Exp Med 1992; 175:779-788.
26. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson D, Giri JG: Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994;264:965-968.
27. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994;13:2822-2830.
28. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA: Endogenous produc tion of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 1995;96:2578-2582.
29. Flamand L, Stefanescu I, Menezes J: Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996;97:1373-1381.
30. Truneh A, Albert F, Golstein P, Schmitt-Verhulst A-M: Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 1985;313:318-320.
31. 2+ of human NK cells. J Immunol 1989;143: 1058-1065.
32. Leibson PJ, Midthun DE, Windebank KP, Abraham RT: Transmembrane signaling during natural killer cell-mediated cytotoxicity: Regulation by protein kinase C activation. J Immunol 1990;145:1498-1504.
33. Ythier A, Delmon L, Reinherz E, Nowill A, Moingeon P, Mishal Z, Bohuon C, Hercend T: Proliferative responses of circulating human NK cells: Delineation of a unique pathway involving both direct and helper signals. Eur J Immunol 1985;15: 1209-1215.
34. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL: Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell Immunol 1991; 135:454-470.
35. Warren HS, Kinnear BF, Skipsey LJ: Human natural killer (NK) cells: Requirements for cell proliferation and expansion of phenotypically novel subpopulations. Immunol Cell Biol 1993;71:87-97.
36. Kovanen PE, Knuutila S, Timonen T: Requirement of CD4+ lymphocytes in IL-2-stimulated NK cell proliferation. Scand J Immunol 1995;41:70-76.
37. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM: Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994;84:3261-3282.
38. Bluestone JA: New perspectives of CD28-B7-mediated costimulation. Immunity 1995;2:555-559.
39. Nandi D, Gross JA, Allison JP: CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J Immunol 1994;152:3361-3369.
40. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL: Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993;177: 845-850.
41. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM: Activated B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993; 90:11059-11063.
42. Hintzen RQ, Lens SMA, Lammers K, Kuiper H, Beckmann MP, van Lier RAW: Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995;154:2612-2623.
43. Davis SJ, van der Merwe PA: The structure and ligand interactions of CD2: Implications for T-cell function. Immunol Today 1996;17:177-187.
44. Sugita K, Robertson MJ, Torimoto Y, Ritz J, Schlossman SF, Morimoto C: Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol 1992;149:1199-1203.
45. Caligiuri MA, Murray C, Robertson MJ, Wang E, Cochran K, Cameron C, Schow P, Ross ME, Klumpp TR, Soiffer RJ, Smith K, Ritz J: Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest 1993;91: 123-132.
46. Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant tumor necrosis factor (TNF)-α: Induction of TNF receptors on human T cells and TNF-α-mediated enhancement of T cell responses. J Immunol 1987; 138:1786-1790
47. Yokota S, Geppert TD, Lipsky PE: Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J Immunol 1988;140:531-536.
48. Jelinek D, Lipsky PE: Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-α and interleukin 1. J Immunol 1987;139:2970-2976.
49. Tucci A, James H, Chicheportiche R, Bonnefoy J-Y, Dayer J-M, Zubler RH: Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay. J Immunol 1992;148:2778-2784.
50. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
51. Roy M, Waldschmidt T, Aruffo A Ledbetter JA, Noelle RJ: The regulation of expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993;151:2497-2510.
52. Miller JS, Oelkers S, Verfaillie C, McGlave P: Role of monocytes in the expansion of human activated natural killer cells. Blood 1992;80-2221-2229.
53. Pierson BA, Gupta K, Hu W-S, Miller JS: Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-β1 and independent accessory cell-derived contact and soluble factors. Blood 1996;87:180-189.
54. London L, Perussia B, Trinchieri G: Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells but only a minor subset of low density T cells. J Immunol 1986;137:3845-3854.
55. Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G: Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat Immun 1987;6:171-188.
56. Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL: Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. J Immunol 1992;149:340-349.
57. Melder J, Whiteside TL, Vujanovic NL, Hiserodt JC, Herberman RB: A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res 1988;48:3461-3469.
58. Vujanovic NL, Rabinowich H, Lee YJ, Jost L, Herberman RB, Whiteside TL: Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell Immunol 1993;151: 133-157.
59. Pierson BA, McGlave PB, Miller JS: Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium. J Hematother 1995;4:149-158.